{"abstract": "The drug maker agreed to pay $688 million to settle two lawsuits that said it had harmed investors by delaying the release of unfavorable study results for a cholesterol drug.", "web_url": "https://www.nytimes.com/2013/02/15/business/merck-settles-investor-suits-over-cholesterol-drug.html", "snippet": "The drug maker agreed to pay $688 million to settle two lawsuits that said it had harmed investors by delaying the release of unfavorable study results for a cholesterol drug.", "lead_paragraph": "Merck has agreed to pay $688 million to settle lawsuits claiming that it had harmed investors by delaying the release of unfavorable study results for its cholesterol drug Vytorin, the company announced on Thursday.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/15/business/subMerck/subMerck-articleLarge.jpg", "height": 833, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2013/02/15/business/subMerck/subMerck-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 833}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/15/business/subMerck/subMerck-jumbo.jpg", "height": 1024, "width": 738, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/15/business/subMerck/subMerck-superJumbo.jpg", "height": 1157, "width": 833, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/15/business/subMerck/subMerck-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2013/02/15/business/subMerck/subMerck-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/02/15/business/subMerck/subMerck-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Merck Settles Suits Over Cholesterol Drug", "kicker": null, "content_kicker": null, "print_headline": "Merck Settles Suits Over Cholesterol Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "persons", "value": "Thomas, Katie", "rank": 2, "major": "N"}, {"name": "subject", "value": "Vytorin (Drug)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Cholesterol", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Schering-Plough Corp", "rank": 5, "major": "N"}, {"name": "subject", "value": "Suits and Litigation", "rank": 6, "major": "N"}, {"name": "subject", "value": "Decisions and Verdicts", "rank": 7, "major": "N"}, {"name": "subject", "value": "Zetia (Drug)", "rank": 8, "major": "N"}], "pub_date": "2013-02-14T19:44:35+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/36e9a1f4-d67c-55c8-9c58-227739111696", "word_count": 757, "uri": "nyt://article/36e9a1f4-d67c-55c8-9c58-227739111696"}